Newsy's Latest Health News

The video discusses the anxiety-related adverse reactions to the Johnson & Johnson COVID-19 vaccine, as analyzed by the CDC. It highlights that the preference for the single-dose J&J vaccine among anxious individuals may contribute to these reactions. The CDC advises monitoring recipients post-vaccination. Additionally, Moderna plans to supply up to 500 million vaccine doses to developing countries through the WHO's COVAX program, addressing the disparity in vaccine distribution between rich and poor nations. The video concludes with acknowledgments to Kaiser Health News.

What did the CDC conclude about the adverse reactions to the Johnson and Johnson COVID vaccine?

• They are caused by the vaccine itself.

• They are linked to anxiety about getting vaccinated.

• They are due to a manufacturing defect.

• They are unrelated to the vaccine or anxiety.

Why might anxious individuals prefer the Johnson and Johnson vaccine?

• It is cheaper than other vaccines.

• It is more effective than other vaccines.

• It is a single-dose vaccine.

• It has fewer side effects.

How many doses of its COVID vaccine does Moderna plan to supply to developing countries?

• 1 billion doses

• 250 million doses

• 500 million doses

• 100 million doses

Through which program will Moderna's vaccines be distributed to 92 low and middle-income countries?

• UNICEF

• GAVI

• WHO Direct

• COVAX

Who is acknowledged for their contribution to the health headlines?

• Moderna

• Kaiser Health News

• Centers for Disease Control and Prevention

• World Health Organization